Bio-Rad Laboratories, Inc. (BIO) Stock Forecast
Data as of May 2, 2026Healthcare · Current price $254.44 (-9.17%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Feb 16, 2026 | Brandon Couillard | Wells Fargo | $320.00 | +25.8% |
| Oct 1, 2024 | Patrick Donnelly | Citigroup | $400.00 | +57.2% |
Top Analysts Covering BIO
BIO vs Sector & Market
| Metric | BIO | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 3.00 | 2.24 | 2.41 |
| Analyst Count | 2 | 8 | 18 |
| Target Upside | +22.8% | +1150.2% | +14.9% |
| P/E Ratio | 41.92 | 6.83 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $2.59B | $2.63B | $2.67B | 3 |
| 2027-03-31 | $612M | $613M | $614M | 1 |
| 2027-06-30 | $683M | $684M | $685M | 1 |
| 2027-09-30 | $701M | $702M | $703M | 1 |
| 2027-12-31 | $739M | $740M | $741M | 1 |
| 2028-03-31 | $626M | $627M | $628M | 1 |
| 2028-06-30 | $699M | $700M | $701M | 1 |
| 2028-09-30 | $721M | $721M | $723M | 1 |
| 2028-12-31 | $759M | $760M | $761M | 1 |
| 2029-12-31 | $2.90B | $2.94B | $2.98B | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $10.10 | $10.29 | $10.47 | 2 |
| 2027-03-31 | $2.84 | $2.84 | $2.85 | 1 |
| 2027-06-30 | $2.79 | $2.79 | $2.80 | 1 |
| 2027-09-30 | $2.88 | $2.88 | $2.89 | 1 |
| 2027-12-31 | $3.29 | $3.29 | $3.30 | 1 |
| 2028-03-31 | $3.49 | $3.50 | $3.50 | 1 |
| 2028-06-30 | $3.16 | $3.16 | $3.17 | 1 |
| 2028-09-30 | $3.26 | $3.27 | $3.27 | 1 |
| 2028-12-31 | $3.43 | $3.44 | $3.44 | 1 |
| 2029-12-31 | $14.03 | $14.30 | $14.55 | 1 |
Frequently Asked Questions
What is the analyst consensus for BIO?
The consensus among 2 analysts covering Bio-Rad Laboratories, Inc. (BIO) is Hold with an average price target of $327.50.
What is the highest price target for BIO?
The highest price target for BIO is $400.00, set by Patrick Donnelly at Citigroup on 2024-10-01.
What is the lowest price target for BIO?
The lowest price target for BIO is $320.00, set by Brandon Couillard at Wells Fargo on 2026-02-16.
How many analysts cover BIO?
2 analysts have issued ratings for Bio-Rad Laboratories, Inc. in the past 12 months.
Is BIO a buy or sell right now?
Based on 2 analyst ratings, BIO has a consensus rating of Hold (3.00/5) with a +22.8% upside to the consensus target of $327.50.
What are the earnings estimates for BIO?
Analysts estimate BIO will report EPS of $10.29 for the period ending 2026-12-31, with revenue estimated at $2.63B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.